SCHEMBL19377455

SCHEMBL19377455

C[C@H](NC(=O)Nc1ccc(S(=O)(=O)Nc2ccc3c(c2)CCNC3)cc1)c1cccc(Cl)c1Cl

nearest known ligand 0.45

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ HTR6 P50406 6/20 0.45
▸ PNMT P11086 1/20 0.45
▸ HTR2C P28335 5/20 0.44
▸ DRD2 P14416 4/20 0.44
▸ DRD3 P35462 4/20 0.44
▸ HTR2A P28223 3/20 0.44
▸ MLNR O43193 1/20 0.42
▸ USP28 Q96RU2 1/20 0.41
▸ HTR2B P41595 2/20 0.41
▸ PCTP Q9UKL6 1/20 0.40
▸ STARD10 Q9Y365 1/20 0.40
▸ IDH1 O75874 1/20 0.40
▸ CYP3A4 P08684 2/20 0.38
▸ CYP1A2 P05177 1/20 0.38
▸ CYP2D6 P10635 1/20 0.38
▸ CYP2C9 P11712 1/20 0.38
▸ CYP2C19 P33261 1/20 0.38
▸ ALDH1A1 P00352 1/20 0.37
▸ LMNA P02545 1/20 0.37
▸ THRB P10828 1/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL19377457 1.00 HTR6 (0.45) HTR6PNMTHTR2CDRD2DRD3
SCHEMBL19377427 0.97 PNMT (0.49) HTR6PNMTHTR2CDRD2DRD3
SCHEMBL19377425 0.97 PNMT (0.49) HTR6PNMTHTR2CDRD2DRD3
SCHEMBL24800739 0.87 HTR6 (0.41) HTR6PNMTHTR2CUSP28HTR2B
SCHEMBL19406944 0.87 HTR6 (0.41) HTR6PNMTHTR2CUSP28HTR2B
SCHEMBL19377495 0.87 HTR6 (0.41) HTR6PNMTHTR2CUSP28HTR2B
SCHEMBL19377509 0.86 PNMT (0.43) HTR6PNMTHTR2CDRD2DRD3
Hydrochloric Acid SCHEMBL19377278 0.86 HTR6 (0.41) HTR6PNMTHTR2CUSP28HTR2B
SCHEMBL19377510 0.86 PNMT (0.43) HTR6PNMTHTR2CDRD2DRD3
SCHEMBL19377656 0.86 MLNR (0.46) HTR6PNMTHTR2CDRD2DRD3

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20170275301-A1 Benzenesulfonyl-Asymmetric Ureas and Medical Uses Thereof HELSINN HEALTHCARE SA (CH) 2017-09-28 — — US claimed
US-20170275301-A1 Benzenesulfonyl-Asymmetric Ureas and Medical Uses Thereof HELSINN HEALTHCARE SA (CH) 2017-09-28 — — US disclosed
US-20170275301-A1 Benzenesulfonyl-Asymmetric Ureas and Medical Uses Thereof HELSINN HEALTHCARE SA (CH) 2017-09-28 — — US disclosed
US-20170275301-A1 Benzenesulfonyl-Asymmetric Ureas and Medical Uses Thereof HELSINN HEALTHCARE SA (CH) 2017-09-28 — — US disclosed
WO-2017162390-A1 BENZENESULFONYL-ASYMMETRIC UREAS AND MEDICAL USES THEREOF HELSINN HEALTHCARE SA (CH) 2017-09-28 — — WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20170275301-A1 Benzenesulfonyl-Asymmetric Ureas and Medical Uses Thereof UTS2R, GHSR, GRPR HTR6 231/4885PNMT 819/4885HTR2C 530/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback